Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05919732 · ClinicalTrials.gov registry record · Phase 4

Awake Caudal Catheter vs General Anesthesia

A Phase 4 study, sponsored by Nemours Children's Clinic.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target

NCT05919732: Completed Phase 4 study, sponsored by Nemours Children's Clinic.

NCT05919732 is a Phase 4 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05919732, a Phase 4 study, has completed, sponsored by Nemours Children's Clinic.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target

Study Summary

It is well established that preterm inguinal hernias discovered in the NICU pose a significant surgical risk due to the associated co-morbid conditions that accompany these patients. Currently, the standard of care in the United States is general anesthesia. There have been studies that have established that elective outpatient repair of inguinal hernias found in the NICU can be safely performed. Patients that are ready for discharge from the NICU will have inguinal hernia repair prior to leaving. Inguinal hernia repair will also be done on those premature infants that are seen in the Nemours surgical clinic. Spinal anesthesia is currently the most common anesthetic procedure used in the surgical treatment of preterm inguinal hernias after general anesthesia. Caudal catheter technique has been proven to safely provide post-operative care of premature infants. The caudal catheter technique involves placement of a small catheter under ultrasound guidance into the caudal epidural canal to allow re-dosing of local anesthetic during the case and has been shown to be safe and effective management in neonates (Somri M, 2007).

Interventions

  • DRUG Bupivacaine, Dexmedetomidine, Caffeine, Tylenol
  • DRUG Propofol, rocuronium, caffeine, Tylenol, bupivacaine

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-03-08
Est. Completion 2018-03-08
Phase Phase 4
Nemours Children's Clinic

108 total trials

What the finished NCT05919732 record still lists

NCT05919732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Bupivacaine, Dexmedetomidine, Caffeine, Tylenol is the first listed.

NCT05919732 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05919732 about?

NCT05919732 is a clinical study titled "Awake Caudal Catheter vs General Anesthesia". It is well established that preterm inguinal hernias discovered in the NICU pose a significant surgical risk due to the associated co-morbid conditions that accompany these patients. Currently, the standard of care in the United States is general anesthesia. There have been studies that have establi...

What is the current status of trial NCT05919732?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2016-03-08. Estimated completion is 2018-03-08.

What interventions are being tested in trial NCT05919732?

The interventions under investigation include: Bupivacaine, Dexmedetomidine, Caffeine, Tylenol (DRUG), Propofol, rocuronium, caffeine, Tylenol, bupivacaine (DRUG).

Who is sponsoring clinical trial NCT05919732?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05919732's enrollment target sits among peer trials

20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05919732, the US trial registry maintained by the National Library of Medicine. NCT05919732 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.